LINDSTROM RICHARD L MD

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
5 60% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 230%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
LINDSTROM RICHARD L MD's trades of Ocular Therapeutix Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-24 2026-02-20
B Purchase
49,174 -37.7%
141.73
US$2,082,076 		49,174 -37.7% 141.73 US$2,082,076
2025-05-12 2025-05-08
B Purchase
4,528 +43.0%
376.12
US$3,591,805 		4,528 +43.0% 376.12 US$3,591,805
2022-10-03 2022-09-30
US Harrow Inc (HROW)
PlS Planned sale
98,262 -28.1%
272.28
US$4,899,905 		98,262 -28.1% 272.28 US$4,899,905
2021-09-27 2021-09-24
US Harrow Inc (HROW)
PlS Planned sale
3,900 -5.6%
10.04
US$39,156 		3,900 -5.6% 10.04 US$39,156
2021-09-17 2021-09-16
US Harrow Inc (HROW)
PlS Planned sale
5,840 -7.7%
9.02
US$52,677 		5,840 -7.7% 9.02 US$52,677
2021-09-17 2021-09-15
US Harrow Inc (HROW)
PlS Planned sale
14,160 -15.7%
9.09
US$128,714 		14,160 -15.7% 9.09 US$128,714
2021-05-21 2021-05-20
US Harrow Inc (HROW)
S Sale
10,000 -10.0%
10.75
US$107,500 		10,000 -10.0% 10.75 US$107,500
2021-05-21 2021-05-20
S Sale
10,000 -10.0%
14.30
US$143,000 		10,000 -10.0% 14.30 US$143,000
2019-03-14 2019-03-13
B Purchase
56,441 +129.6%
4.33
US$244,390 		56,441 +129.6% 4.33 US$244,390